Litcius/Paper detail

Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax resistance in human small cell lung cancer

Zsuzsanna Valkó, Zsolt Megyesfalvi, Anna Schwendenwein, Christian Lang, Sándor Paku, Nándor Bárány, Bence Ferencz, Anita Horváth-Rózsás, Ildikó Kovács, Erzsébet Schlegl, Veronika Pozonec, Kristiina Boettiger, Melinda Rezeli, György Marko‐Varga, F Rényi-Vámos, Mir Alireza Hoda, Thomas Klikovits, Konrad Höetzenecker, Michael Grusch, Viktória László, Balázs Döme, Karin Schelch

2023British Journal of Cancer42 citationsDOIOpen Access PDF

Topics & Concepts

VenetoclaxCancer researchLung cancerApoptosisMedicineCellCancerBiologyOncologyImmunologyLeukemiaInternal medicineGeneticsChronic lymphocytic leukemiaCell death mechanisms and regulationLung Cancer Research StudiesCancer, Stress, Anesthesia, and Immune Response
Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax resistance in human small cell lung cancer | Litcius